St. Francis Cancer Center | St. Francis Cancer Center | Available Clinical Trials
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
421
page-template,page-template-full_width_inside,page-template-full_width_inside-php,page,page-id-421,page-child,parent-pageid-283,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.9,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Available Clinical Trials

Search Clinical Trials

To view available Clinical Trials, search using the fields below. For more information about an available trial, contact our Oncology Research Department at 864-603-6211.

Available Clinical Trials

Search by Type: or
Reset

Displaying All Clinical Trials (76)
A011202
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection …
A011401
Randomized Phase III Trial Evaluating the Role of Weight Loss …
A021502
Alliance A021502 - Randomized Trial of Standard Chemotherapy Alone or …
A031501
A031501 - Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) …
A031704
Alliance A031704 - “PD-inhibitor (Nivolumab) and Ipilimumab followed by nivolumab …
A041501
A041501 - A Phase III Trial to Evaluate the Efficacy …
A041701
A041701 - A Randomized Phase II/III Study of Conventional Chemotherapy …
A041702
A041702 - A Randomized Phase III Study of Ibrutinib Plus …
A051301
A051301 - A randomized double-blind phase III study of ibrutinib …
A051701
A051701 - Randomized phase II/III study of venetoclax (ABT 199) …
A081105
Randomized Study of Erlotinib Vs Observation in Patients With Completely …
A081801
Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST …
A151216
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). …
A211601 Companion to A011502
Evaluation of Mammographic Breast Density Effect of Aspirin: A companion …
A221505
A221505 - RT CHARM: Phase III Randomized Trial of Hypofractionated …
AGCT1531
AGCT1531: A Phase 3 Study of Active Surveillance for Low …
AMG 510 20190009
A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of …
Amgen 20190014
A Phase 4, Multi-center Open-label Feasibility Study to Evaluate Outpatient Blinatumomab Administration …
Apollomics APL 101-01
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, …
Arcus AB122CSP0002
A Phase 1b Study to Evaluate the Safety and Clinical …
Bayer DaroAct 20609
Bayer 20609, "A randomized, open-label, multicenter, Phase 2b study to …
BMS CA209-592
An Exploratory Study of the Biologic Effects and Biomarkers of …
BMS CA209-914
A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination …
CCTG MA.39
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer …
Conjupro UV1-202
A Randomized Phase II, Open‑label, Active‑controlled, Multicenter Study Investigating the Efficacy …
Daiichi Sankyo DS8201-A-U303
A PHASE 3, MULTICENTER, RANDOMIZED, OPENLABEL, ACTIVE-CONTROLLED TRIAL OF DS-8201A, …
E4412
A Phase I Study with an Expansion Cohort/Randomized Phase II …
E4512
A Phase III Double-Blind Trial for Surgically Resected Early Stage …
EA1131
Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. …
EA2176
A Phase III Study of Immune checkpoint inhibition with chemotherapy …
EA2182
A Randomized Phase II Study of De-intensified Chemoradiation for Early …
EA3161
EA3161 - A Phase II/III Randomized Study of Maintenance Nivolumab …
EA4151
EA4151 - A Randomized Phase III Trial of Consolidation with …
EA6134
EA6134 - A Randomized Phase III Trial of Dabrafenib + …
EA6141
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim …
EA8143
EA8143 – A Phase 3 RandOmized Study Comparing PERioperative Nivolumab …
EA9131
EA9131 - A Simplified Patient Care Strategy to Decrease Early …
EA9161
EA9161 - A Randomized Phase III Study of the Addition …
EAA181
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase …
EFC15858
Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel …
Exact Sciences 2018-01
Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated …
Galera GTI 4419-301
ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419) – …
Galera GTI-4419-203
A Phase 2A Open-Label Trial of the Effects of Intravenous …
Genmab GCT1015-05
A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy …
GOG 0263
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation …
GSK 209229
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or …
Infinity IPI 549 02
A Phase 2, Multicenter, Randomized, Double-Blind, Active-Control Study to Evaluate …
Merck MK3475-667
An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) …
Merck MK3475-671
A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy …
Merck MK3475-966
A Phase 3 Randomized, Double Blind Study of Pembrolizumab Plus …
MK 4375-992
A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study …
NCICOVID
COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History …
NHLBI-MDS
The National Myelodysplastic Syndromes (MDS) Study
NRG BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin …
NRG GY006
A Randomized Phase II Trial of Radiation Therapy and Cisplatin …
NRG GY009
A Randomized, Phase II/III Study of Pegylated Lipsomal Doxorubicin and …
NRG LU005
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III …
NRG LU007
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for …
NRG-CC004
NRG-CC004 - Phase II Double Blind Dose Finding Trial of …
NRG-GU002
NRG-GU002 - Phase II-III Trial Of Adjuvant Radiotherapy and Androgen …
NRG-LU002
NRG-LU002 - Maintenance Systemic Therapy versus Consolidative Stereotactic Body Radiation …
NSABP B-51
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and …
PUMA NER-5201
AN OPEN-LABEL, PHASE 2 STUDY OF NERATINIB IN PATIENTS WITH …
QUILT 2.023
A PHASE 2, OPEN-LABEL, RANDOMIZED STUDY OF N-803, A FUSION …
QUILT 3.055
A Phase 2b, Single-Arm, Multicohort, Open-Label Study of ALT-803 in …
S1608
Randomized Phase II Trial in Early Relapsing or Refractory Follicular …
S1609
DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors | …
S1801
S1801 - A Phase II Randomized Study of Adjuvant Versus …
S1803
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or …
S1815
S1815 - A Phase III Randomized Trial of Gemcitabine, Cisplatin, …
SGNLVA-005
Open Label Phase II Study of Ladiratuzumab Vedotin (LV) for …
SWOG S1714
S1714 - A Prospective Observational Cohort Study to Develop a …
SWOG S1826
S1826 - A Phase III, Randomized Study of Nivolumab (Opdivo) …
Takeda Ponatinib-3001
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus …
URCC 18007
Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue | >>Read …
WF-1802
Influence of Primary Treatment for Prostate Cancer on Work Experience …